Transforming Adolescent Mental Health Through Accessible, Scalable, Technology-supported Small-group Instruction
Launched by UNIVERSITY OF OREGON · May 12, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving mental health for teenagers who may be experiencing anxiety, depression, or thoughts of self-harm. The researchers aim to use a method called Cooperative Learning (CL), which involves small group activities that encourage teamwork and positive peer relationships. By using technology to help deliver these lessons, the program hopes to make it easier for schools to implement and reach more students effectively.
The trial is currently looking for participants, which includes students and teachers in certain grades at selected schools. There are no specific restrictions on who can join, so if you're in the right age group and attend one of the participating schools, you could be eligible. Participants can expect to engage in supportive group activities that not only aim to improve mental health but also promote better academic performance. This program offers an exciting opportunity to help young people connect with each other while learning valuable skills to manage their emotions and challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All students and teachers in target grades in participating schools.
- Exclusion Criteria:
- • None.
About University Of Oregon
The University of Oregon is a leading research institution dedicated to advancing scientific knowledge and improving public health through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its expertise in various fields, including psychology, neuroscience, and public health, to conduct rigorous studies that address critical health challenges. Committed to ethical research practices and participant welfare, the University of Oregon fosters an environment of academic excellence, driving forward the discovery of new treatments and interventions that enhance the quality of life for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tempe, Arizona, United States
Eugene, Oregon, United States
Madison, Wisconsin, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported